Immune Response BioPharma, Fredericksburg, Virginia Today 5/26/2011 privately held, plans to File NDA’s for both Remune and RemuneX: Remune with Adjuvant by the end of 2011, and sees both as approvable as well safe and effective treatment options for HIV/AIDS with key biomarkers of significant increases in CD8+ counts based upon further review of data collected on Remune and Remune with Adjuvant both show a strong correlation of increase in CD8+ KillerT-Cells this is an important treatment option that should be made available to patients with both HIV and full blown AIDS as it is a more safer and humane treatment option without the toxic effects of the anti-retroviral-drugs. Data confirms Remune offers a partial control of HIV immunity the longer a patient stays off the anti-retroviral-drugs and on Remune the longer it takes for the virus to reach peak viral loads.
There is no magic bullet for defeating this evil virus called HIV and AIDS, after reviewing the data collected from all of the clinical trials on Remune and RemuneX it is clear there are significant benefits to the whole-killed virus vaccine and IRBP has concluded this is a viable and safer treatment option for patients. The first thing we can gather from the numerous clinical trials is the patient’s immune system gets a break from the anti-retroviral drugs and the toxic side effects of those drugs. The second benefit is an strong increase in the biomarkers CD8+ KillerT-Cell counts actually increased significantly over a long period of treatments with Remune this is key and more important biomarker in which the CD8+ KillerT-Cells come in and destroy the bad virus infected cells. The vaccine gives patients a HAART stopping option by controlling the viral load and boosting the immune system.
“This is a bad virus which will take a combination of treatments to eradicate it from the body and Remune along with RemuneX offer beneficial treatment options for doctors and their patients. You have to hit this evil virus very hard, with all available treatment options should be on the table for patients. Again there is no silver bullet to wipe out this evil virus but patients deserve to have the treatment option and it is the humane and right thing to do to give ill patients the vaccine and offer hope to them. Restarting the Remune program and the company is the right thing to do, it is paramount that action be taken to halt a pandemic of epic proportions” Mr. Buswell COO IRBP.
“Those who have criticized Remune in the past are out of touch with reality there is no perfect solution to this awful disease and unless you have a better less toxic treatment it would be best to keep your comments to yourself. I would not want to be on the FDA panel voting against Remune and telling patients they can’t have the vaccine. It is a tragic situation that patients have not had access to Remune. Patients need immediate and real help now and I urge the FDA to act quickly and clear Remune for commercialization, some patients have little time left, it is of grave importance that they receive the treatment. If you-re not part of the solution you-re part of the problem” Mr. Buswell COO IRBP.
